Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.06. | NSE - Fresh2 Group Ltd - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
11.06. | Delisting of Securities of Blue Star Foods Corp.; Altamira Therapeutics Ltd.; Evergreen Corporation; Fresh2 Group Limited; Coliseum Acquisition Corp.; The Real Good Food Company, Inc.; Mynaric AG; byNordic Acquisition Corporation; ... | 390 | GlobeNewswire (Europe) | NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Blue Star Foods Corp. Blue Star Foods Corp.'s stock was suspended on December... ► Artikel lesen | |
02.04. | Fresh2 Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
11.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.02.2025 | 499 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.02.2025ISIN NameCA53635T1084 LIQUID... ► Artikel lesen | |
FRESH2 GROUP Aktie jetzt für 0€ handeln | |||||
22.08.24 | Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq | 298 | GlobeNewswire (Europe) | New York, NY, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or the "Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry... ► Artikel lesen | |
10.07.24 | XFRA 0UC: AUSSETZUNG/SUSPENSION | 442 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFRESH2 GROUP SP.ADS/200... ► Artikel lesen | |
10.07.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 10.07.2024 | 516 | Xetra Newsboard | The following instruments on XETRA do have their first trading 10.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.07.2024
Aktien
1 AU0000249831 Clara Resources Australia... ► Artikel lesen | |
09.07.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.07.2024 | 490 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 09.07.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.07.2024ISIN NameCA38238W1032 GOODNESS... ► Artikel lesen | |
09.07.24 | XFRA ISIN CHANGE | 622 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03635R2067 Fresh2 Group Ltd. 09.07.2024 US03635R3057 Fresh2 Group Ltd. 10.07.2024 Tausch 10:1CA38238W1032 Vireo... ► Artikel lesen | |
09.07.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.07.2024 | 779 | Xetra Newsboard | Das Instrument MTSA US6068272029 MITSUI + CO. ADR/20 EQUITY wird cum Kapitalmassnahme gehandelt am 09.07.2024 und ex Kapitalmassnahme am 10.07.2024 The instrument MTSA US6068272029 MITSUI + CO. ADR/20... ► Artikel lesen | |
08.07.24 | Fresh2 Group Ltd: Fresh2 Group Limited Announces 1-for-10 Reverse ADS Split | 289 | GlobeNewswire (Europe) | New York, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GERRESHEIMER | 48,680 | -0,33 % | Gerresheimer-Aktie verliert 3,41 Prozent (46,48 €) | Der Anteilsschein von Gerresheimer notiert heute etwas leichter. Die Aktie kostete zuletzt 46,48 Euro. Ein Abschlag von 3,41 Prozent steht gegenwärtig für der Anteilsschein von Gerresheimer zu Buche.... ► Artikel lesen | |
TELADOC HEALTH | 7,023 | +0,10 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
ROKU | 73,81 | -1,34 % | BofA ups PT for Roku on Amazon partnership, improving advertiser sentiment | ||
BICO GROUP | 3,260 | -0,31 % | Toni Haberthür, CEO Bico / Hilding Anders Switzerland, im Interview | von Patrick Gunti Moneycab.com: Herr Haberthür, Bico steht «für ä tüüfä gsundä Schlaaf» und ist seit Jahrzehnten die bekannteste Marke der Schweiz im Bereich hochwertiger Schlaflösungen. Wie prägt die... ► Artikel lesen | |
PLUS THERAPEUTICS | 0,301 | -2,18 % | Plus Therapeutics Inc.: Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ in Leptomeningeal Metastases | Primary objective to determine optimal dosing schedule for a registrational trial Trial builds on recommended Phase 2 dose determined in completed Phase 1 trial Trial benefits from $17.6M award... ► Artikel lesen | |
MCKESSON | 604,60 | -1,27 % | EchoIQ: Das KI-Unternehmen, das Ihr Herz retten - und Ihr Portfolio beflügeln könnte | ||
ATOSSA THERAPEUTICS | 0,715 | +1,13 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
UNIDOC HEALTH | 0,115 | -3,36 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
CO-DIAGNOSTICS | 0,238 | -1,65 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
NETRAMARK | 0,855 | +3,01 % | Übernahmefieber! BioTech und Künstliche Intelligenz beflügelt Evotec, NetraMark Holdings, NovoNordisk und Bayer | Derzeit erlebt der Biotech-Sektor eine spannende Transformation: Denn Big Data und Künstliche Intelligenz verändern in rasanter Art und Weise, wie neue Medikamente entdeckt, entwickelt und getestet... ► Artikel lesen | |
CYTOSORBENTS | 0,917 | +2,57 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
VERU | 0,501 | -3,09 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
VOLITIONRX | 0,756 | -1,47 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
ONTRAK | 0,500 | +3,50 % | Ontrak, Inc. - 8-K, Current Report |